The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 17, 2025
Filed:
Jul. 02, 2020
Applicant:
Orion Corporation, Espoo, FI;
Inventors:
Susanna Ilmonen, Espoo, FI;
Juha Lintunen, Espoo, FI;
Petteri Lyytinen, Espoo, FI;
Marko Saalasti, Espoo, FI;
Assignee:
ORION CORPORATION, Espoo, FI;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4155 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4155 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/28 (2013.01); A61K 9/2813 (2013.01); A61K 9/2826 (2013.01); A61K 9/2853 (2013.01); A61K 9/2866 (2013.01);
Abstract
The present invention relates to a pharmaceutical composition for oral administration, particularly in the form of a tablet, comprising darolutamide or a pharmaceutically acceptable salt thereof as an active ingredient. Darolutamide is a potent androgen receptor (AR) modulator useful in the treatment of cancer, particularly AR dependent cancer such as prostate cancer, and other diseases where AR antagonism is desired.